Approximately 10% of ccRCC patients in the TCGA cohort showed mutational signatures consistent with ERCC2 inactivation associated NER deficiency and also substantial levels of PTGR1 expression. The gene discussed is PTGR1; the disease is nonpapillary renal cell carcinoma.